JAY BUCHANAN Wants Next RIVAL SONS Album To Be 'Really, Really Rough' And 'Really Unrefined'

Why It Matters

The shift toward a gritty sound could revitalize Rival Sons’ market position, while the health‑related delay impacts release timing and associated revenue streams.

Key Takeaways

• Next Rival Sons album aims for raw, unrefined sound
• Band likely to retain Dave Cobb as producer
• Release timeline uncertain due to frontman's wife's cancer
• Writing will blend pre‑written material with floor sessions
• Buchanan emphasizes fun collaboration with guitarist Scott Holiday

Pulse Analysis

Jay Buchanan’s recent comments signal a deliberate pivot toward a more visceral aesthetic for Rival Sons’ next record. Citing the 1992 Black Crowes’ “Southern Harmony and Musical Companion” as a template, he wants a “black T‑shirt” album that feels “tooth‑ache raw,” stripping back the polished layers that have characterized recent releases such as “Darkfighter” and “Lightbringer.” This move aligns with a broader resurgence of gritty, analog‑driven rock that appeals to listeners fatigued by over‑produced pop. By embracing a rougher sonic palette, the band hopes to recapture the immediacy of early‑career live performances while differentiating the upcoming LP in a crowded market.

The production partnership with veteran producer Dave Cobb remains a cornerstone of the band’s strategy. Cobb, who has overseen nine Rival Sons records, functions almost as a fifth member in the studio, offering shorthand communication and a shared creative language. His track record of delivering Grammy‑nominated rock albums adds commercial credibility, and his familiarity with the group can expedite the recording of a raw‑edge project without sacrificing cohesion. Industry observers note that such long‑term producer‑artist relationships often yield consistent brand identity, which can translate into stronger radio support and streaming playlist placement for a new, high‑impact release.

However, the album’s timeline is clouded by personal circumstances. Buchanan disclosed that his wife received a breast‑cancer diagnosis in December, prompting him to prioritize her treatment and pause studio work. This delay could push the release into 2026, affecting promotional cycles and tour planning that typically follow a new record. From a business perspective, the uncertainty may influence label budgeting, merchandising roll‑outs, and festival bookings that rely on fresh material. Nonetheless, the band’s commitment to delivering the record once health challenges subside underscores a fan‑first ethos, which could bolster loyalty and long‑term revenue once the album finally arrives.